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ABSTRACT
Leptospirosis is an anthropozoonosis caused by Leptospira interrogans. It occurs worldwide and is
endemic in French Polynesia. Leptospirosis is associated with a large variety of clinical symptoms. Most
infections caused by leptospires are either sub-clinical or of very mild severity, but 5–10% of infections
result in multiple organ damage, including kidney, liver and lung lesions. Among 71 patients
hospitalised in Papeete for severe leptospirosis during a period of 2 years, the main risk-factors for a
severe outcome were hypotension, oliguria and an abnormal chest auscultation at the ﬁrst physical
examination. Survival depends on rapid diagnosis and early appropriate management. Well-deﬁned
criteria may help physicians to improve the timely treatment of high-risk patients.
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Leptospirosis is an anthropozoonosis caused by
Leptospira interrogans, and is thought to be the
most widespread zoonosis in the world [1]. The
source of infection in man is usually either direct
or indirect contact with the urine of an infected
animal. The incidence of this disease is signiﬁ-
cantly higher in countries with a warm climate
than in temperate regions [2], mainly because of
the longer survival capacity of leptospires in the
environment in warm, humid conditions. The
disease is seasonal, with the peak incidence in
summer or autumn in temperate regions (where
temperature is the limiting factor in the survival
of leptospires), and during rainy seasons in
warmer regions such as French Polynesia.
The usual portal of entry of the infecting organ-
ism is through abrasions or cuts in the skin or via
the conjunctiva.Waterborne transmission has been
documented, and contamination of water supplies
has resulted in several outbreaks of leptospirosis
[2]. Inhalation of water or aerosols may also result
in infection via the mucous membranes of the
respiratory tract. Thus, infections in man may be
acquired through occupational and recreational
exposure. There is a signiﬁcant risk associatedwith
direct occupational contact with infected animals
or during recreational water sports [2]. Animals,
including man, can be divided into maintenance
hosts or accidental hosts. The disease is main-
tained by chronic infection of the renal tubules of
maintenance hosts [2].
Leptospirosis is associatedwith a large variety of
clinical symptoms. Most infections caused by
leptospires are either sub-clinical or of very mild
severity. Patients present typically with a febrile
illness of sudden onset,while other symptomsmay
include chills, headache, myalgia, abdominal pain,
conjunctival suffusion and, less often, a skin rash.
This anicteric syndrome lasts for about 1 week.
Subsequently, 5–10% of infections result in mul-
tiple organ damage, including kidney, liver and
lung lesions. Weil’s syndrome is the most severe
form of this infection, characterised by febrile
illness with haemorrhagic tendencies, hepatic dys-
function and acute renal failure, and can result in a
fatal outcome in a short time if left untreated.
Laboratory diagnosis of leptospirosis can be
made by microscopic visualisation of leptospires
in clinical material by dark-ﬁeld microscopy, by
immunoﬂuorescence, or by light microscopy after
appropriate staining. Detection of leptospiral
antigens in clinical material would offer greater
speciﬁcity than would dark-ﬁeld microscopy.
Most cases of leptospirosis are diagnosed by
serology. Antibodies are detectable in the blood
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at 5–7 days after the onset of symptoms. The
reference method for serological diagnosis is the
microscopic agglutination test, in which patient
sera are reacted with live antigen suspensions of
leptospiral serovars.
Diagnosis of leptospirosis can also be deﬁned
in accordance with WHO recommendations [3],
where a diagnostic ‘score’ is obtained, based on
six clinical criteria, two laboratory-determined
criteria and an epidemiological criterion. Lepto-
spirosis is suspected when the score is ‡ 20, with a
strong presumption when the score is ‡ 24.
Prognostic factors associated with mortality
have only been evaluated in a very few studies.
In our Polynesian hospital, 71 severe cases of
leptospirosis were studied retrospectively during
a period of 2 years. All 71 patients were admitted
to the intensive care unit. Following multivariate
analysis, three independent variables were found
to be associated signiﬁcantly with severity after
stepwise logistic regression analysis, i.e., oliguria,
hypotension and abnormal chest auscultation (the
presence of crackles or rhonchi). These symptoms
are consistent with those reported in other series
[4]. The mortality rate of 7% was within the range
of 4–10% reported in studies from France [5] and
the USA [6]. Differences in the mortality rate can
be attributed to the criteria chosen for patient
inclusion and to the severity of the disease.
There have been few attempts to deﬁne prog-
nostic factors for leptospirosis. In the French West
Indies, Dupont et al. [7] showed that delayed
management was not an independent factor pre-
dicting a poorer outcome. Renal failure is reported
frequently in patients with leptospirosis (17–71%
of cases) [8,9], and oliguria was an independent
prognostic factor (p < 0.05) in our own series.
Multivariate analysis has shown previously [7,9]
that the mortality rate for oliguric patients with
acute renal failure is higher than that for patients
with persistent diuresis (p < 0.006 and p < 0.003,
respectively). The incidence of pulmonary involve-
ment in leptospirosis varies between 17% [4] and
70% [10,11]. Courtin et al. [12] showed that the
mortality rate rose from4.8% to 11%whenpatients
developed respiratory symptoms.Among our own
cases, 45% of patients had respiratory symptoms,
and three died from acute respiratory distress
syndrome. Crackles or rhonchi at chest ausculta-
tion were independent factors associated with
severity (p < 0.007). However, Dupont et al. [7]
showed that the presence of alveolar inﬁltrates was
a poor prognostic factor in severe leptospirosis.
Cardiac involvement is probably more common
than is reported. In our experience, electrocardio-
gram (ECG) abnormalities were seen in 22 (31%)
patients, and similar abnormalities (i.e., abnormal
T waves) were detected in 39% of patients in The
Philippines [12]. Repolarisation abnormalities on
ECG are considered to be a poor prognostic
indicator (OR 5.9; p < 0.0001) for severe leptos-
pirosis [7]. However, none of the patients in our
own series died because of cardiac involvement.
Other studies have indicated that cardiovascular
collapse is not an indicator of a poor prognosis [7].
In conclusion, physicians in tropical areas need
to be aware of prognostic factors associated with
severe leptospirosis, such as oliguria, abnormal
chest auscultation or abnormal chest X-ray and
cardiac involvement. These factors can be identi-
ﬁed easily at the ﬁrst clinical examination, and
should help to reduce mortality by allowing
earlier management of patients with suspected
leptospirosis.
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